Last edition
News about "Fasenra benralizumab biosimilar"
Samsung Bioepis and Teva Expand Biosimilar Partnership
Samsung Bioepis and Teva expand their strategic partnership to develop and commercialise up to 6 biosimilar candidates across the US, Europe and Canada.
Fasenra Benralizumab Biosimilar | 03/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members